Prioritization in inflammatory bowel disease therapy

KR Herrlinger, EF Stange - Expert Review of Gastroenterology & …, 2023 - Taylor & Francis
Introduction Most guidelines for IBD still recommend step-by-step therapy with initially
classic drugs such aminosalicylates (in ulcerative colitis) or steroids but avoid prioritizing …

[PDF][PDF] Faecal Microbiota Transplantation [FMT] in the Treatment of Chronic Refractory Pouchitis: A Systematic Review and Meta-analysis

S Zaman, A Akingboye… - Journal of Crohn's …, 2024 - academic.oup.com
Background The aim of this systematic review and meta-analysis is to assess the efficacy
and safety of faecal microbiota transplantation [FMT] in the treatment of chronic pouchitis …

Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in …

P Eder, M Łodyga, M Gawron-Kiszka… - Gastroenterology …, 2023 - termedia.pl
Objective The main objective of this document is to complete the guidelines already in force
to include new information, particularly regarding new medicines which have been …

Effectiveness and safety of tofacitinib in patients with chronic pouchitis multirefractory to biologics

M Uzzan, M Nachury, A Amiot… - Digestive and Liver …, 2023 - dldjournalonline.com
Up to 30% of patients with ulcerative colitis (UC) will require a colectomy. Current guidelines
recommend to perform an ileal pouch-anal anastomosis (IPAA) as restorative surgery …

Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD

J Ampuero, R Gallego-Durán, D Maya-Miles… - Journal of …, 2022 - Springer
Background NAFLD clinical trials have shown suboptimal results, particularly for liver
fibrosis, despite the robust preclinical drug development. We aimed to assess the …

Approach to Therapy for Chronic Pouchitis

M Kayal, B Boland - Annual Review of Medicine, 2025 - annualreviews.org
Chronic pouchitis (CP) occurs in approximately 20% of patients with ulcerative colitis after
total proctocolectomy with ileal pouch anal anastomosis and is categorized as antibiotic …

Vedolizumab subcutaneous formulation maintenance therapy for patients with IBD: a systematic review and meta-analysis

Q Hu, X Tang, F Liu, D Liu… - Therapeutic advances in …, 2023 - journals.sagepub.com
Background: The application of vedolizumab (VDZ) subcutaneous (SC) formulation has
brought more convenience and hope to patients with moderate-to-severe inflammatory …

Network meta-analysis: efficacy of treatment for acute, chronic, and prevention of pouchitis in ulcerative colitis

S Poo, D Sriranganathan, JP Segal - European Journal of …, 2022 - journals.lww.com
Methods Biomedical databases and the Cochrane Central registry were searched between
1978 and 2021 for randomised controlled trials examining treatment for acute, chronic and …

Treatment patterns and standardized outcome assessments among patients with inflammatory conditions of the pouch in a prospective multicenter registry

EL Barnes, P Deepak, P Beniwal-Patel… - Crohn's & Colitis …, 2022 - academic.oup.com
Background Much of our understanding about the natural history of pouch-related disorders
has been generated from selected populations. We designed a geographically diverse …

Treatment of antibiotic refractory chronic pouchitis with JAK inhibitors and S1P receptor modulators: an ECCO CONFER Multicentre Case Series

DG Ribaldone, G Testa, B Verstockt… - Journal of Crohn's …, 2024 - academic.oup.com
Abstract Background and Aims Data regarding the effectiveness and safety of Janus kinase
[JAK] inhibitors and sphingosine-1-phosphate [S1P] receptor modulators in antibiotic …